RSC Pharmaceutics Blog

We are very excited to introduce you to Andy Lewis, Yahya Choonara, Dimitrios Lamprou, Raju Vivek, Lingling Shen and Hitesh Kulhar as part of the inaugural Advisory Board for RSC Pharmaceutics!

Dr Andy Lewis is Chief Scientific Officer, Quotient Sciences, UK. He has over 20 years experience working in the pharmaceutical and biotech industry focussed on advanced drug delivery technologies particularly protein and peptide drug delivery, solubility enhancement and controlled release.

“I look forward to joining the Advisory Board for the new RSC Pharmaceutics journal and supporting its development into a world leading journal for pharmaceutical scientists. As it’s a Gold Open Access journal researchers publishing in it can be confident of a wide dissemination of their work to help build their reputation.”- Dr Andy Lewis

Professor Yahya Choonara is part of Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology in the School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand located in Johannesburg, South Africa.

“I am pleased to serve on the Advisory Board of RSC Pharmaceutics which is a top-tier platform for advancing the frontier of pharmaceutical innovation and communicating the latest science in drug delivery, formulation, and discovery. The journal provides a vibrant and inclusive space for scientists from diverse backgrounds to share ideas, challenge assumptions, and shape the future of pharmaceutical science for the betterment of global health” – Professor Yahya. Choonara

Professor Dimitrios Lamprou is a Full Professor (Chair) of Biofabrication and Advanced Manufacturing and Director at MSc Industrial Pharmaceutics at Queen’s University Belfast School of Pharmacy. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS), Committee Member of the British Standards Institute (BSI) AMT/8 for Additive Manufacturing, and Visiting Professor in a number of international Institutions

“I am very familiar with the Royal Society of Chemistry(RSC) journals and values, is an honour to be part of this family. With this appointment, I will be able to further support the journal, weed out low-quality contributions, guarantee the calibre of the articles that are published, and, at the same time, boost the topic. Pharmaceutics is an important field and this new journal will bring research more visual to researchers in the field by bringing fundamental and advanced research to them, supporting the development of advanced Drug Delivery Systems (DDSs)”.– Professor Dimitrios Lamprou

Dr. Raju Vivek is an Assistant Professor of Bharathiar University located in India.

“I am thrilled to be a part of the advisory board for RSC Pharmaceutics, a platform that showcases cutting-edge research in the field of pharmaceutics. As a member of the board, I am excited to contribute to the publication of innovative studies that will shape the future of pharmaceutical research. RSC Pharmaceutics is dedicated to highlighting novel discoveries and advancements in pharmaceutics, with a focus on high-potential therapeutics research. I look forward to working with the team to establish the journal as a leading voice in the field and to fostering the sharing of groundbreaking ideas and findings”– Dr. Raju Vivek

Dr Lingling Shen, is an Associate Director of Data Science and Discovery Sciences at Novartis Biomedical Research.

“RCS Pharmaceutics aims to be the ideal platform for all researchers including those from the industry, to share their work, even with confidentiality constraints. I’m excited about the journal’s supportive and efficient publishing process and hopeful it will grow to become a leading publication in the field.” – Dr Lingling Shen

Dr. Hitesh Kulhar is part of the School of Nano Sciences at the Central University of Gujarat located in Gandhinagar, India

“It is a privilege to be a part of the Royal Society of Chemistry (RSC) which is one of the oldest research and scientific communities and the subject of Pharmaceutics is close to my heart. So, I feel honored and delighted to be part of RSC Pharmaceutics.

RSC Pharmaceutics is a unique forum to provide communication between pharmaceutical formulation researchers, scientists and industries. It will showcase the research advances made in the areas of drug delivery, drug targeting and precision medicines.” – Dr. Hitesh Kulhar

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are thrilled to introduce you to Scott Mitchell, Sara Cordeiro, Twan Lammers, Eliana Lima, Avi Schroeder and Faisal Razato as part of our inaugural RSC Pharmaceutics Advisory Board!

Dr Scott Mitchell is from the Aragón Nanoscience and Materials Institute (INMA), Spanish National Research Council (CSIC) in Spain.

“The Royal Society of Chemistry has a track record of opening new avenues to disseminate transdisciplinary research. Health research containing elements of synthetic and analytical chemistry, materials design, nanoformulation, and interaction of drug delivery systems with biological models requires a dedicated space in the academic publishing ecosystem. I hope to provide insights that can help the RSC Pharmaceutics editors enhance this offering and attract high-quality submissions in this particular area.” – Dr Scott Mitchell

Dr Ana Sara Cordeiro is from the Leicester School of Pharmacy at De Montfort University in Leicester, UK.

“I am excited to join the Advisory Board for RSC Pharmaceutics, which is bound to become of the reference journals in our field. Interdisciplinarity is key to achieve real impact in improving healthcare and patients’ lives, and the intersection between drug chemistry and formulation design continues to be essential in the overall pharmaceutical development process. RSC Pharmaceutics is the perfect home for the top studies advancing knowledge in this field, and I am delighted to contribute to this journal at this point in its journey.”- Dr Ana Sara Cordeiro

Professor Twan Lammers is from the Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging,in the Center for Biohybrid Medical Systems at RWTH Aachen University Clinic, located in Aachen, Germany

Professor Eliana Lima is from the Universidade Federal de Goias  in Brazil

“I am excited to be part of RSC Pharmaceutics, as it represents a unique opportunity to connect with a global community dedicated to advancing pharmaceutical science. The journal is committed to publishing high-quality research that addresses current challenges and innovations in the field, offering a platform for impactful discoveries, fostering collaboration, and ensuring rigorous peer review to maintain scientific excellence.” – Professor Eliana Lima

Professor Avi Schroeder is from Technion at the Israel Institute of Technology.

Dr. Faisal Raza is from the School of Pharmacy at the Shanghai Jiao Tong University located in Shanghai, China.

“I am thrilled to join the Advisory Board of RSC Pharmaceutics because it aligns perfectly with my passion for advancing the field of pharmaceutics. Publishing in this journal offers the unique benefit of high visibility and accessibility, given its gold open access model. Researchers should consider submitting their work to RSC Pharmaceutics for its commitment to scientific excellence and its supportive editorial team.”– Dr Faisal Raza

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to Naved Malek, Audra Stinchcomb, Priyabrata Mukherjee, Wilson Poon, Emily Day and Anthony Hickey as part of our inaugural RSC Pharmaceutics Advisory Board!

Dr Naved Malek is an Associate Professor at the Ionic Liquids Research Laboratory in the Department of Chemistry at Sardar Vallabhbhai National Institute of Technology located in Surat, India.

“RSC journals come with scientific excellence, quality and are highly regarded across various scientific communities. RSC Pharmaceutics with its targeted audience can enhance the visibility and credibility of the work that meets high standards of scientific rigor and innovation in the field of drug delivery, formulation, and physicochemical and biological properties of drugs and their carriers.” – Professor Naved Malek

Professor Audra L. Stinchcomb is currently a Professor in the School of Pharmacy at the University of Maryland in Baltimore, USA.

“The Royal Society of Chemistry has a long history of high impact chemistry journals, so of course Pharmaceutics is an important addition to the collection.  I am pleased to be part of a journal focused on transparent peer review and the scientists who make a difference in bringing the world quality pharmaceuticals.” – Professor Audra L. Stinchcomb

Professor Priyabrata Mukherjee is a PHF-Presidential Professor and a Professor of Pathology at University of Oklahoma Health Sciences Center. He is also a Peggy and Charles Stephenson Endowed Chair of Laboratory Cancer Research, Senior Director for Research Partnership and Collaboration at the Stephenson Cancer Center and Co-Director of the Nanomedicine Program.

Dr Wilson Poon is an Assistant Professor in the Department of Metallurgical, Materials and Biomedical Engineering at the University of Texas at El Paso

“I wanted to be involved with RSC Pharmaceutics because together, I think we can push the next generation of drug formulation and delivery science forward.”– Dr Wilson Poon

Dr Emily Day is currently an Associate Professor of Biomedical Engineering at the University of Delaware, in the USA.

“I am excited to support RSC Pharmaceutics as this journal will provide a venue for researchers to share their most exciting work at the leading edge of drug development and delivery.”- Dr Emily Day

Professor Anthony Hickey is Professor Emeritus in the Eshelman School of Pharmacy and Adjunct Professor in the Department of Biomedical Engineering of the School of Medicine of The University of North Carolina at Chapel Hill.

“RSC Pharmaceutics is a new forum addressing the demand for exchange of data, knowledge and ideas emerging from scientific and technological advances in novel therapeutic modalities, due to contemporary insights into the origins and mechanism of disease. Publications in the journal support the framework of understanding required to address the needs of disease therapy in the 21^st Century.”- Professor Anthony Hickey

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce our inaugural Advisory Board for RSC Pharmaceutics! Our Advisory Board is comprised of internationally renowned researchers working within the field of pharmaceutics.

Please join us in welcoming our new Advisory Board members:

• Andrew Lewis, Quotient Sciences, UK
• Audra Stinchcomb, School of Pharmacy, University of Maryland, USA
• Avi Schroeder, Technion, Israel Institute of Technology, Isreal
• Dimitrios Lamprou, Queens University Belfast, Northern Ireland
• Eliana Lima, Universidade Federal de Goias, Brazil
• Faisal Raza, Shanghai Jiao Tong University, China
• Lingling Shen, Novartis, USA
• Priyabrata Mukherjee, University of Oklahoma Health Sciences Centre, USA
• Raju Vivek, Bharathiar University, India
• Scott Mitchell, Aragón Nanoscience and Materials Institute (INMA), Spain
• Anthony Hickey, University of North Carolina at Chapel Hill, USA
• Twan Lammers, RWTH Aachen University Clinic, Germany
• Naved Malek, Sardar Vallabhbhai National Institute of Technology, India
• Wilson Poon, University of Texas at El Paso, USA
• Emily Day, University of Delaware, USA
• Hitesh Kulhari, Central University of Gujarat, India
• Yahya Choonara, University of the Witwatersrand, South Africa
• Sara Cordeiro, Leicester School of Pharmacy, De Montfort University, UK

We are excited to welcome our new Advisory Board members to our journal community and look forward to working with them as we shape and grow the journal.

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Professor Arvind Kumar Bansal.

Professor Bansal is currently a Dean and Professor at the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER) – SAS Nagar, Punjab, India.

“I am honoured and excited for my new role as Editorial Board Member of RSC Pharmaceutics. The journal shall capture cutting-edge advancements in the diverse domains of drug delivery and pave the way for better medicines. I look forward to working with the highly accomplished editorial team.”

Read more about Professor Bansal here.

Read some of Professor Bansal’s research:

Study on Sulfamethoxazole–Piperazine Salt: A Mechanistic Insight into Simultaneous Improvement of Physicochemical Properties
Parag Roy, Soumalya Chakraborty, Noopur Pandey, Nimmy Kumari, Sourav Chougule, Amrita Chatterjee, Kaberi Chatterjee, Pallab Mandal, Bapi Gorain, Ananta V. Dhotre, Arvind Kumar Bansal, Animesh Ghosh
Molecular Pharmaceutics, 2023, 20, 5226-5239

Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery
Prashantkumar K. Parmar, Jhanvi Wadhawan, Arvind K. Bansal
Drug Discovery Today, 2021, 10, 2329-2349

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Professor Heidi Mansour.

Professor Mansour is currently a Professor and Program Leader of Drug Discovery and Delivery at the Florida International University (FIU) Center for Translational Science located in Port Saint Lucie, Florida, on the beautiful Treasure Coast.

“As an Associate Editor, I am delighted and honored to be a part of the expert team that serves the newly launched RSC Pharmaceutics. Having published in RSC journals, I am excited to promote this premier journal to our peers and scientific community. I look forward to RSC Pharmaceutics being a leading journal in the field.”

Read more about Professor Mansour here.

Read some of Professor Mansour’s research here:

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
David Encinas-Basurto, John P. Konhilas, Robin Polt, Meredith Hay and Heidi M. Mansour
Pharmaceutics, 2022, 14, 587

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
Priya Muralidharan, Evan K. Mallory, Monica Malapit, Hanna Phan, Julie G. Ledford, Don Hayes, Jr and Heidi M. Mansour
RSC Adv., 2020, 10, 41846-41856

Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway
Priya Muralidharan, Don Hayes, Jr., Stephen M. Black and Heidi M. Mansour
Mol. Syst. Des. Eng., 2016, 1, 48-65

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor Assaf Zinger.

Dr. Assaf Zinger is a leading researcher and educator specializing in nanomedicine and engineering. He is currently an Assistant Professor at the Technion-Israel Institute of Technology and an Adjunct Assistant Professor at the Houston Methodist Academic Institute in Texas, USA. Dr. Zinger’s research focuses on biomimetic nanoparticles, covering various fields from biochemical engineering, where he designs and tests these nanoparticles, to biomedical engineering, where he assesses their effectiveness against conditions like neurodegenerative diseases, brain injuries, and cancers.

“I was drawn to this journal because of its unwavering commitment to publishing ground breaking discoveries in pharmaceutical science and its awesome editorial board. I am hoping that publishing here will not be just about sharing your research; it will be about contributing to the future of medicine.”

Read more about Dr. Zinger here.

Read some of Dr Zinger’s research:

Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications
Assaf Zinger
J. Controlled Release, 2023, 358, 591-600

Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles
Assaf Zinger, Manuela Sushnitha, Tomoyuki Naoi, Gherardo Baudo, Enrica De Rosa, Jenny Chang, Ennio Tasciotti and Francesca Taraballi
ACS Nano, 2021, 15, 6326-6339

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Professor Xiaoxuan Liu.

Professor Xiaoxuan Liu is a Professor at the Center of Advanced Pharmaceuticals and Biomaterials in China Pharmaceutical University. Her research interest focuses on the development of novel dendrimer based nanosystems via modular self-assembling process for on-demand delivery of drugs and nucleic acid therapeutics in precision medicine.

Read more about Professor Liu here.

Read some of Professor Liu’s research here:

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers
Jiaxuan Chen, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding, Qiulin Long, Yang Wang, Erik Laurini, Wenjun Lan, Yun Li, Aura Tintaru, Caoyun Ju, Can Zhang, Sabrina Pricl, Juan Iovanna, Xiaoxuan Liu and Ling Peng
Proc. Natl. Acad. Sci. U.S.A., 2023, 120, e2220787120

A biodegradable amppnas.org/doi/10.1073/pnas.2220787120hiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery
Chi Ma, Dandan Zhu, Wenyi Lin, Ying Li, Yuanzheng Huang, Huiling Zhu, Mengyun Ye, Yang Wang, Ling Peng and Xiaoxuan Liu
Chem. Commun., 2022, 58, 4168-4171

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Yongchao Wang, Ningqiang Gong, Chi Ma, Yuxuan Zhang, Hong Tan, Guangchao Qing, Jimei Zhang, Yufei Wang, Jinjin Wang, Shizhu Chen, Xianlei Li, Qiankun Ni, Yuan Yuan, Yaling Gan, Junge Chen, Fangzhou Li, Jinchao Zhang, Caiwen Ou, Yongxiang Zhao, Xiaoxuan Liu and Xing-Jie Liang
Nat. Commun., 2021, 12, 4964

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our RSC Pharmaceutics Associate Editor, Professor Clare Hoskins.

Professor Clare Hoskins is a Professor of Nanomedicine within the Department of Pure and Applied Chemistry, University of Strathclyde. Her research focusses on the development of various nanotechnology platforms for drug delivery and theranostics, with a special focus on cancer nanomedicine.

You can find out more about Professor Hoskins here.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement and submit your manuscript on our webpage.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to Professor Yvonne Perrie, Editor-in-Chief of the new Royal Society of Chemistry journal RSC Pharmaceutics.

Yvonne Perrie is a Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland. Professor Perrie’s research is multi-disciplinary and focuses on developing drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. Read more on our webpage.

Read some of Professor Perrie’s research here:

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
Giulia Anderluzzi, Gustavo Lou, Stuart Woods, Signe Tandrup Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner and Yvonne Perrie
J. Control. Release, 2022, 342, 388-399

Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly
Saphia A. L. Matthew, Refaya Rezwan, Jirada Kaewchuchuen, Yvonne Perrie and F. Philipp Seib
RSC Adv., 2022, 12, 7357-7373

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement on our webpage.

RSC Pharmaceutics opens for submissions later this year, sign up for e-alerts to be the first to find out news about the journal.